Breast abscess

Summary

Breast abscess (MONDO:0000749) is a disease and 6 clinical trials. Top therapeutic interventions include methylene blue cation. A subtype of breast disorder — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Clinical trials: 6

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	breast abscess
Mondo ID	MONDO:0000749
DOID	DOID:0060323
ICD-11	1033306788
SNOMED CT	28432003
UMLS	C0151463
MedGen	508760
Is cancer (heuristic)	no

Disease family

This is a subtype of breast disorder. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › breast disorder › breast abscess

Related subtypes (14): hypertrophy of breast, fat necrosis of breast, breast angiomatosis, breast adenosis, benign mammary dysplasia, breast fibrocystic disease, mastitis, familial juvenile hypertrophy of the breast, supernumerary breasts, isolated congenital breast hypoplasia/aplasia, syndromic breast hypoplasia/aplasia, breast neoplasm, lactation disease, breast implant illness

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 6.

Phase distribution (across all retrieved trials)

Phase	Trials
Not specified	5
PHASE2	1

Top trials by phase / activity

NCT	Phase	Status	Title
NCT07179003	PHASE2	NOT_YET_RECRUITING	A Phase 2 Study of Methylene Blue Photodynamic Therapy for Treatment of Breast Abscesses
NCT06594276	Not specified	RECRUITING	Comparison of Efficacy in Treating Breast Abscess, With Systemic Antibiotics Against Local Instillation of Antibiotics Along With Ultrasound Guided Aspiration.
NCT03730467	Not specified	WITHDRAWN	Puncture Breast Abscess
NCT06225180	Not specified	TERMINATED	Review of Breast Abscess Management
NCT06951373	Not specified	COMPLETED	Comparison of Multiple Percutaneous Needle Aspiration Versus Incision and Drainage in Small Breast Abscesses: Pain, Cosmesis, and Early Breastfeeding Outcomes
NCT07588412	Not specified	COMPLETED	Comparison of Standard Incision and Drainage Versus Percutaneous Suction Drainage in the Management of Acute Breast Abscess

Drugs tested across these trials (top 30)

Molecule	Max phase	Trials referencing
METHYLENE BLUE CATION	4	3